Trade Summary

2 days ago, McCulloch Kevin, serving as See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 15,000 shares at $8.49 per share, for a total transaction value of $127,308.00. Following this transaction, McCulloch Kevin now holds 1,639,208 shares of XERS.

This sale represents a 0.91% decrease in McCulloch Kevin's stake in the company.

The trade was executed on Tuesday, September 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 at 6:21 PM ET, meaning the disclosure happened on the same day as the trade.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.